Headquarters
Taiwan
Every company in the roster headquartered in Taiwan.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
8 of 8 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 AP Biosciences Inc.6945 · TPEx | 1 asset: 1 Ph 2 | AP203Phase 1/2 · Non-Small Cell Lung Cancer | Dec 2026AP203 · Phase 1/2 |
BiopeuticsPrivate | 1 asset: 1 Ph 3 | alprostadilPhase 3 · Heart FailurePartial signal | Nov 2029alprostadil · Phase 3 |
 Foresee Pharmaceuticals6576 · TPEx | 1 asset: 1 Ph 2 | MirivadelgatPhase 2 · Hypertension | Feb 2028Mirivadelgat · Phase 2 |
 ImmunworkPrivate | 1 asset: 1 Ph 2 | TE-8105Phase 1/2 · ObesityWeak signal | None on record |
 Meridigen BiotechPrivate | 1 asset: 1 Ph 2 | UMC119-06Phase 2 · Chronic Obstructive Pulmonary DiseaseWeak signal | None on record |
| 1 asset: 1 Ph 2 | TML-6Phase 2 · Alzheimer's DiseasePartial signal | 30 Apr 2028TML-6 · Phase 2 | |
 PharmaEngine4162 · TPEx | 1 asset: 1 Ph 1 | PEP07Phase 1 · Acute Myeloid Leukemia | 31 Dec 2026PEP07 · Phase 1 |
 Polaris Group6550 · TWSE | 1 asset: 1 Ph 3 | PegargiminasePhase 3 · Acute Myeloid LeukemiaWeak signal | 28 Feb 2027Pegargiminase · Phase 2 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).